News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Week in Review: Tongjitang Chinese Medicines Company (TCM) Upping the Stakes


8/23/2010 8:04:39 AM

August 21, 2008 -- Tongjitang Chinese Medicines Co. is still considering the $4.50 per ADS buyout offer from its Chairman/CEO and Fosun Industrial; GSK will purchase an additional 9% of its vaccine JV with Neptunus Interlong; Accord Pharma will pay $4 million for the rest of Sinopharm Traditional Chinese Medicine; China approved the merger between Novartis and eye-products company Alcon with conditions; Jiangbo Pharma received manufacturing approval for a hypertension drug; Sinovac Biotech’s revenues are lower now that the fear of flu is abating; and Sinopharm Group will locate its antibiotic manufacturing center in Datong City, Shanxi province. More details….

Read at BioSpace.com
Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES